Jhaveri CD, Liu D, Maguire MG, Glassman AR, et al. Risk Factors for Meeting Criteria for Switching from Bevacizumab to Aflibercept When Treating Eyes with Diabetic Macular Edema and Visual Acuity <20/40. Ophthalmology 2024 Feb 7:S0161-6420(24)00098.
PMID: 38336282